Small cell lung cancer (SCLC) accounts for about 15% of lung cancer cases and is categorized into limited and extensive stages. Treatment options include radiation, chemotherapy, and immunotherapy ...

Non-small-cell lung cancer (NSCLC) is the most common type of cancer affecting the lungs. The diverse types of NSCLC are characterized by cancer cells that grow and spread in different ways.

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune response, and tumor progression, though more research is needed. According ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Novel therapies targeting molecular pathways, including DLL3 and PARP inhibitors, show promise in improving SCLC survival outcomes. Tarlatamab, a DLL3-targeting bispecific T-cell engager, achieved ...

Penderita small cell lung cancer (SCLC) jika dibandingkan dengan ... Inc., telah dilakukan pada Sabtu (9/3) lalu. Ini adalah langkah lanjutan setelah Kalbe mendapatkan izin edar di Indonesia ...

Lung cancer was originally classified according to how tumour cells appeared under a microscope. Non-small cell lung cancer (NSCLC) is by far the most common form, representing about 85% of all ...

Read more about A study using a blood sample to diagnose cancer (PREVAILctDNA) A study of active surveillance for small cell lung cancer that has a risk of spreading to the brain (PRIMALung study) ...